- Report
- October 2023
- 552 Pages
Global
From €4562EUR$4,799USD£3,901GBP
- Report
- October 2023
- 1600 Pages
Global
€3798EUR$3,995USD£3,248GBP
- Report
- October 2023
- 250 Pages
Global
From €5699EUR$5,995USD£4,874GBP
- Report
- November 2023
- 450 Pages
Global
From €3798EUR$3,995USD£3,248GBP
- Report
- October 2023
- 200 Pages
Global
From €5699EUR$5,995USD£4,874GBP
- Report
- October 2023
- 100 Pages
Global
€3798EUR$3,995USD£3,248GBP
- Report
- October 2023
- 100 Pages
Global
€3798EUR$3,995USD£3,248GBP
- Report
- October 2023
- 150 Pages
Global
From €5699EUR$5,995USD£4,874GBP
- Report
- October 2023
- 450 Pages
Global
€3798EUR$3,995USD£3,248GBP
- Report
- October 2023
- 400 Pages
Global
€3798EUR$3,995USD£3,248GBP
- Report
- March 2023
- 296 Pages
Global
From €4562EUR$4,799USD£3,901GBP
- Report
- February 2024
- 867 Pages
Global
From €5608EUR$5,899USD£4,796GBP
- Report
- August 2023
- 190 Pages
Global
From €4562EUR$4,799USD£3,901GBP
- Report
- January 2024
- 34 Pages
Global
From €4562EUR$4,799USD£3,901GBP
- Report
- April 2023
- 75 Pages
Global
From €3565EUR$3,750USD£3,049GBP
- Report
- March 2024
- 102 Pages
Global
From €1616EUR$1,700USD£1,382GBP
- Report
- April 2023
- 76 Pages
Global
From €1331EUR$1,400USD£1,138GBP
- Report
- March 2023
- 128 Pages
Global
From €4744EUR$4,990USD£4,057GBP
- Report
- December 2023
Global
From €4611EUR$4,850USD£3,943GBP
- Report
- August 2023
- 270 Pages
Global
From €2329EUR$2,450USD£1,992GBP
The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more